CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novo Nordisk Inc. v. Sandoz Inc.

1:09-cv-09217

Overview

Case Number 1:09-cv-09217
Filing Date 2009-11-05
Status Terminated
Termination Date 2011-08-16
Court District Court, S.D. New York (nysd)
Nature of Suit 830 Patent
Jurisdiction Type Federal question
Cause of Action 35:271 Patent Infringement

Parties

Defendant

Sandoz Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Novo Nordisk Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, S.D. New York (nysd)

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

2

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Motion for Preliminary Injunction / TRO 2

Key Dispositive Motions & Rulings

Motion for Preliminary Injunction / TRO Pending / Under Review
ORDER FOR ADMISSION PRO HAC VICE ON WRITTEN MOTION granting [14] Motion for Laura A. Lydigsen to Appear Pro Hac Vice. Laura A. Lydigsen is admitted to practice ...
Entry #15 • 2010-01-26 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
STIPULATION AND ORDER: Defendant's time to file an answer or motion addressed to the Complaint shall be extended to 12/30/09. In the event Defendant files a mot...
Entry #7 • 2009-11-30 Document →

Docket Entries

(47 total)
Pleading / Complaint

COMPLAINT against Sandoz Inc. (Filing Fee $ 350.00, Receipt Number 705246)Document filed by Novo Nordisk Inc., Novo Nordisk A/S.(ama) (ama).

Entry #1 • 2009-11-05
1

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Novo Nordisk A/S.(ama) (ama).

Entry #2 • 2009-11-05
1

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Novo Nordisk US Holdings, Inc.; Novo Nordisk A/S; as Corporate Parent. Document filed by Novo Nordisk Inc.(ama) (ama).

Entry #3 • 2009-11-05
1
Pleading / Complaint

CERTIFICATE OF SERVICE of Summons and Complaint. Sandoz Inc. served on 11/9/2009, answer due 11/30/2009. Service was accepted by Kevin Vohnoutka, registered agent. Document filed by Novo Nordisk Inc.; Novo Nordisk A/S. (Wu, Aric)

Entry #4 • 2009-11-20
1

MOTION for Wayne M. Barsky to Appear Pro Hac Vice. Document filed by Novo Nordisk Inc., Novo Nordisk A/S.(dle)

Entry #5 • 2009-11-20
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc